LRA Congratulates Equillium on Positive Results of Study of Potential New Lupus Treatment
March 30, 2021
Equillium, Inc. announced positive topline data from the phase 1b EQUALISE study in patients with systemic lupus...
Equalise
Great News for Lupus Nephritis Treatment: Itolizumab Fast-Tracked by FDA
December 10, 2019
The Lupus Research Alliance (LRA) is pleased to share that a potential new treatment in development by...
LRA Pleased to Share News of Lupus Nephritis Clinical Trial Launch
October 1, 2019
The Lupus Research Alliance is pleased to share news about the launch of EQUALISE, a Phase 1b...